Related Experiment Video
Updated: Jun 8, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Urticarial hypersensitivity reaction caused by temozolomide
Salma Pothiawala1, Mei-Yu Hsu, Clarissa Yang
1Department of Dermatology and Cutaneous Surgery, University of South Florida College of Medicine, Tampa, FL, USA.
Abstract:
Temozolomide is an oral alkylating agent approved for the treatment of glioblastoma and anaplastic astrocytoma, and is currently under clinical investigation for the treatment of brain metastases from a variety of cancers. Temozolomide is well tolerated, and the reported dermatologic side effects of this medication are limited. Here, the authors report the first case of an urticarial hypersensitivity reaction induced by temozolomide. As this drug will likely be increasingly utilized in the near future, it is important to be aware of its potential to cause adverse cutaneous manifestations.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Drug toxicity: Idiosyncratic Reactions
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
